Skip to main content
. 2020 Aug 17;14(8):e0008536. doi: 10.1371/journal.pntd.0008536

Table 4. Associations between characteristics of Shigella-attributable diarrhea episodes and culture positivity among 736 attributable diarrhea episodes tested by qPCR and culture1.

Episode characteristic N episodes N (%) culture positive Univariable2
Risk ratio (95% CI)
Multivariable3
Risk ratio (95% CI)
Age (months)
    0–5 15 1 (6.7) 0.25 (0.04, 1.70) 0.19 (0.02, 1.51)
    6–11 116 13 (11.2) 0.53 (0.31, 0.92) 0.51 (0.30, 0.88)
    12–17 246 44 (17.9) 0.82 (0.59, 1.14) 0.86 (0.62, 1.20)
    18–23 326 68 (20.9) 1. 1.
Severe (score ≥4) 211 35 (16.6) 0.91 (0.64, 1.28) --3
Blood 103 30 (29.1) 1.53 (1.09, 2.15) 1.84 (1.28, 2.65)
Fever 225 35 (15.6) 0.69 (0.47, 1.01) 0.66 (0.45, 0.95)
Prolonged (≥7 days) 137 29 (21.2) 0.88 (0.60, 1.29) 0.84 (0.55, 1.29)
Persistent (≥14 days) 26 6 (23.1) 0.89 (0.40, 1.96) --3
Dehydration 71 20 (28.2) 1.22 (0.80, 1.86) 1.17 (0.77, 1.78)
Vomiting 131 22 (16.8) 0.89 (0.59, 1.36) 1.13 (0.73, 1.75)
No. loose stools (mean; SD) 5.8 (2.64) 6.0 (2.37) 1.01 (0.96, 1.06) 1.03 (0.97, 1.09)
Any antibiotic treatment in the last 15 days 420 65 (15.5) 0.87 (0.63, 1.20) --3
Macrolide treatment in the last 15 days 146 10 (6.9) 0.64 (0.33, 1.22) 0.57 (0.30, 1.08)
Cephalosporin treatment in the last 15 days 66 14 (21.2) 1.04 (0.64, 1.69) 0.95 (0.57, 1.60)
Fluoroquinolone treatment in the last 15 days 77 9 (11.7) 0.95 (0.52, 1.73) 0.71 (0.38, 1.32)

1Analysis excludes Brazil, South Africa, and Tanzania, which had 5 or fewer culture-positive attributable diarrhea episodes

2Adjusted for site

3Adjusted for other characteristics included in the table; estimates are excluded for composite (collinear) variables